Literature DB >> 1709069

Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus.

R W Hendriks1, M De Weers, R G Mensink, M E Kraakman, I F Mollee-Versteegde, A J Veerman, L A Sandkuyl, R K Schuurman.   

Abstract

The Wiskott-Aldrich syndrome (WAS) is characterized by severe recurrent infections, petachiae and chronic eczema. The syndrome involves differentiation disorders in several haematopoietic cell lineages usually manifested as T lymphocyte deficiency, dysgammaglobulinaemia and thrombocytopenia. The defect is inherited in an X-linked recessive mode. A 1-year-old boy presented with otitis, upper respiratory infections, eczema, a persistent granulocytopenia and a dysgammaglobulinaemia. In his family five males in two generations had been shown to have WAS, which entailed a significant risk for the patient to have WAS. As the WAS gene or gene product is not delineated, the symptoms of the patient presented a diagnostic dilemma. If the boy had inherited the disease, his mother should be a WAS carrier. Segregation analysis in the family using the closely linked restriction fragment length polymorphisms (RFLP) DXS7, DXS255 and DXS14 did not exclude her carriership, although the probability was low. As a result of the differentiation arrest, obligate female WAS carriers manifest a unilateral X chromosome inactivation pattern in several haematopoietic cell lineages. Methylation analysis of the X chromosomal DXS255 loci exposed random X chromosome inactivation patterns in the peripheral blood granulocytes, T lymphocytes and B lymphocytes of the patient's mother. These findings excluded her WAS carriership and therefore excluded the diagnosis of WAS in the patient. This was further substantiated in a 1-year follow up with recovery from the haematological and immunological symptoms. These results demonstrated that X inactivation analysis in maternal leucocytes is decisive in the exclusion of the diagnosis of WAS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709069      PMCID: PMC1535400     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea.

Authors:  R A ALDRICH; A G STEINBERG; D C CAMPBELL
Journal:  Pediatrics       Date:  1954-02       Impact factor: 7.124

2.  Methylation patterns at the hypervariable X-chromosome locus DXS255 (M27 beta): correlation with X-inactivation status.

Authors:  Y Boyd; N J Fraser
Journal:  Genomics       Date:  1990-06       Impact factor: 5.736

3.  Isolation and characterization of a human variable copy number tandem repeat at Xcen-p11.22.

Authors:  N J Fraser; Y Boyd; I Craig
Journal:  Genomics       Date:  1989-07       Impact factor: 5.736

4.  A highly informative X-chromosome probe, M27 beta, can be used for the determination of tumour clonality.

Authors:  G Abrahamson; N J Fraser; J Boyd; I Craig; J S Wainscoat
Journal:  Br J Haematol       Date:  1990-03       Impact factor: 6.998

5.  Evidence for male X chromosomal mosaicism in X-linked agammaglobulinemia.

Authors:  R W Hendriks; E J Mensink; M E Kraakman; A Thompson; R K Schuurman
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

6.  Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome.

Authors:  M Peacocke; K A Siminovitch
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers.

Authors:  S P Kwan; L A Sandkuyl; M Blaese; L M Kunkel; G Bruns; R Parmley; S Skarshaug; D C Page; J Ott; F S Rosen
Journal:  Genomics       Date:  1988-07       Impact factor: 5.736

8.  X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect.

Authors:  W L Greer; P C Kwong; M Peacocke; P Ip; L A Rubin; K A Siminovitch
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

9.  Carrier detection in the Wiskott Aldrich syndrome.

Authors:  E R Fearon; D B Kohn; J A Winkelstein; B Vogelstein; R M Blaese
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

10.  Evidence that in X-linked immunodeficiency with hyperimmunoglobulinemia M the intrinsic immunoglobulin heavy chain class switch mechanism is intact.

Authors:  R W Hendriks; M E Kraakman; I W Craig; T Espanol; R K Schuurman
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

View more
  8 in total

Review 1.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

2.  Differential methylation at the 5' and the 3' CCGG sites flanking the X chromosomal hypervariable DXS255 locus.

Authors:  R W Hendriks; M E Kraakman; R G Mensink; R K Schuurman
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

3.  Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS.

Authors:  L D Notarangelo; O Parolini; F Porta; F Locatelli; A Lanfranchi; M Marconi; L Nespoli; A Albertini; I W Craig; A G Ugazio
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

4.  X chromosome inactivation analysis to distinguish sporadic cases of X-linked agammaglobulinaemia from common variable immunodeficiency.

Authors:  I Tsuge; H Matsuoka; T Abe; Y Kamachi; S Torii
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

5.  Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome.

Authors:  Y L Lau; B M Jones; L C Low; S N Wong; N K Leung
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

6.  Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.

Authors:  M F Fey; H J Peter; H L Hinds; A Zimmermann; S Liechti-Gallati; H Gerber; H Studer; A Tobler
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Genetic study of a new X-linked recessive immunodeficiency syndrome.

Authors:  G de Saint-Basile; F Le Deist; M Caniglia; Y Lebranchu; C Griscelli; A Fischer
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome: localization to Xq12-q21.31 by X inactivation and linkage analysis.

Authors:  R J Gibbons; G K Suthers; A O Wilkie; V J Buckle; D R Higgs
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.